HCA Healthcare, Inc. $HCA Shares Sold by Amundi

Key Points

• Amundi has reduced its stake in HCA Healthcare by 37.7%, selling 175,175 shares and now holding 289,848 shares valued at approximately $101.2 million.
• Several hedge funds adjusted their positions in HCA Healthcare, with notable increases including Brown Advisory, which raised its holdings by 53.9%, and J.W. Cole Advisors, which lifted its stake by 145.3%.
• HCA Healthcare recently announced a quarterly dividend of $0.72 per share, representing a 0.7% dividend yield, with the ex-dividend date set for September 16th.

Amundi reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 37.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 289,848 shares of the company's stock after selling 175,175 shares during the period. Amundi owned approximately 0.12% of HCA Healthcare worth $101,198,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Brown Advisory Inc. boosted its position in shares of HCA Healthcare by 53.9% during the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock valued at $1,600,000 after acquiring an additional 1,622 shares during the last quarter. Farther Finance Advisors LLC raised its position in shares of HCA Healthcare by 26.9% during the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after buying an additional 242 shares during the period. Oppenheimer Asset Management Inc. increased its stake in HCA Healthcare by 2.5% during the first quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock worth $1,491,000 after acquiring an additional 105 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of HCA Healthcare by 17.6% in the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock valued at $1,704,000 after purchasing an additional 737 shares during the last quarter. Finally, J.W. Cole Advisors Inc. boosted its stake in HCA Healthcare by 145.3% during the first quarter. J.W. Cole Advisors Inc. now owns 3,550 shares of the company's stock worth $1,227,000 after buying an additional 2,103 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Robert W. Baird boosted their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a report on Thursday, August 14th. Bank of America boosted their price target on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a research note on Wednesday. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday, August 26th. Finally, Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $403.17.

HCA Healthcare Stock Down 4.7%

Shares of HCA Healthcare stock traded down $19.23 during trading on Wednesday, hitting $394.17. 1,566,123 shares of the stock were exchanged, compared to its average volume of 1,535,099. The stock has a market cap of $92.23 billion, a price-to-earnings ratio of 16.57, a price-to-earnings-growth ratio of 1.31 and a beta of 1.41. The firm's 50-day moving average price is $381.31 and its 200 day moving average price is $361.47. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $420.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the previous year, the business earned $5.50 EPS. HCA Healthcare's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.